Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
about
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLDUric acid in metabolic syndrome: From an innocent bystander to a central playerPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenMetabolic factors and chronic hepatitis C: a complex interplayRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisOvarian senescence increases liver fibrosis in humans and zebrafish with steatosis.Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortalitySerum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese menAssociation between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease.Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver DiseaseThe Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective StudiesHigher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes.Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.The relevance of hyperuricemia and metabolic syndrome and the effect of blood lead level on uric Acid concentration in steelmaking workersClinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosisSerum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis.Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Determination of anti-inflammatory activities of standardised preparations of plant- and mushroom-based foods.The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candiSarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China.Visceral fat predominance is associated with non-alcoholic fatty liver disease in Japanese women with metabolic syndrome.Clinical relevance of liver histopathology and different histological classifications of NASH in adults.The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH).Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver diseaseImportance of the selected cut-offs for serum uric acid and lipids levels.The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population.
P2860
Q26748461-6D92AAB4-9A2F-4B23-80CE-B4A43EBF46A2Q26772053-910F1DFD-702B-4CD4-BFDA-B76045AA66D6Q26861095-FA816EB1-108D-4263-9349-C6A14A575809Q27011787-4A365D86-0043-4598-B8AC-E59F6489406CQ28354735-4AF35DA7-09CA-4820-AEA5-1A62DDF811EFQ30402192-07696AC5-2FA4-433D-9EA5-D9E19A07C758Q30572017-7996A501-3B57-4012-B181-3E492078CB6DQ33693601-B97C46B4-7725-4E53-93A3-CBA723B181E8Q34462446-A04F3598-DF7D-4F3A-A7D1-8570012597B7Q34877729-3FD9B822-3777-4017-AC3C-F4FE934A108CQ34917717-C9F12934-CCDA-49D8-A265-8C238269A630Q35092860-6E0ABD9D-2218-41B9-B0CA-A6EBEFF70A8CQ35810113-2074AA44-6760-4866-88D1-300427520970Q35870004-89A0F362-0744-446C-A750-FE39D796B126Q35927066-1148FAAC-5F6B-45C9-9467-2D369C73C86EQ36099467-19946EE8-3B47-4EC8-B8C6-72476EC05452Q36120653-F90A0ED9-365C-467F-9F67-5F8DE2B42566Q36127895-87ED6FD8-7A5D-4F8F-AD03-96DC7D0227E6Q36301391-92661C05-242A-438A-82E4-21C5F944408DQ36418940-6B3CC892-B11D-40E9-AB5D-1787C3841328Q37095101-C6ECCE1F-0672-40DD-863D-BECB027BB8B2Q37106734-2D5963B4-1253-44DD-A26D-120ADB077D54Q37581874-9024C767-019B-4CEC-82F3-005F435C7C95Q37672242-52461300-BF63-4A66-9FAA-065DDA4F9DC8Q38314588-C97482AE-443F-46F4-8F82-36ADCC787AC9Q38670507-C01D10FB-13C1-4FE3-A144-9E8631CDF240Q38752520-8C07619F-5FAB-4256-91DE-DD9B1E229A99Q39154883-E4FE3240-0DA8-4B75-8EAD-21CA14FE5089Q40088550-C27791A6-56BE-499F-9949-B95E026EEEE7Q40405220-C7AB44E5-C05C-43DE-A47D-99970DCB42E6Q42981990-625F9987-2545-4801-B72A-29D1B54C0B42Q44037265-900878C9-3585-40CE-B99E-C058F79021D6Q46194979-D7F19865-7910-4D1A-81DB-F7215B1ED619Q47581786-E2BCEEDC-4CF1-4CA3-A5F5-21492590A566Q50059733-52DC0191-2627-402F-A4C4-FCB361664FA2Q50147806-CC0BC3CA-9ACA-4212-B9F8-9E11E897E1A7Q51357634-527C5D07-06EF-499E-9E1E-738F43276B68Q53100804-02A95CD8-7824-4817-B813-3383581F7503Q55403574-0C5B1ECA-F84D-44B4-A36C-C7CA8C84213FQ55620377-96927A20-74B4-4A5B-8C52-CB0F32D70C55
P2860
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Hyperuricemia is associated wi ...... alcoholic fatty liver disease.
@en
Hyperuricemia is associated wi ...... alcoholic fatty liver disease.
@nl
type
label
Hyperuricemia is associated wi ...... alcoholic fatty liver disease.
@en
Hyperuricemia is associated wi ...... alcoholic fatty liver disease.
@nl
prefLabel
Hyperuricemia is associated wi ...... alcoholic fatty liver disease.
@en
Hyperuricemia is associated wi ...... alcoholic fatty liver disease.
@nl
P2860
P50
P1476
Hyperuricemia is associated wi ...... -alcoholic fatty liver disease
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2011.04788.X
P407
P577
2011-07-25T00:00:00Z